SCHEMBL24023377

SCHEMBL24023377

CCOC(=O)C(C)c1cc(-c2sc(N=C(c3ccccc3)c3ccccc3)nc2C)ccn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC7 O00311 2/20 0.36
▸ DBF4 Q9UBU7 2/20 0.36
▸ MAPK14 Q16539 10/20 0.35
▸ IKBKB O14920 1/20 0.34
▸ MAPK13 O15264 1/20 0.34
▸ PRKD3 O94806 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ FLT4 P35916 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ FRK P42685 1/20 0.34
▸ MAPK8 P45983 1/20 0.34
▸ MAPK9 P45984 1/20 0.34
▸ CSNK1A1 P48729 1/20 0.34
▸ CSNK1D P48730 1/20 0.34
▸ CSNK1E P49674 1/20 0.34
▸ MAPK12 P53778 1/20 0.34
▸ CSNK1G2 P78368 1/20 0.34
▸ PTK6 Q13882 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24023419 0.82 CDC7 (0.40) CDC7DBF4MAPK1SMN1; SMN2LMNA
SCHEMBL24023424 0.80 PIK3CA (0.38) CDC7DBF4MAPK14IKBKBMAPK13
SCHEMBL24023330 0.79 OPRM1 (0.36) CDC7DBF4MAPK14NPSR1KDM4E
SCHEMBL24023370 0.79 PIK3CA (0.37) CDC7DBF4MAPK14IKBKBMAPK13
SCHEMBL24023374 0.79 CDC7 (0.39) CDC7DBF4SMN1; SMN2ALDH1A1MEN1
SCHEMBL24023248 0.78 MAPK14 (0.37) MAPK14IKBKBMAPK13PRKD3MAP4K4
SCHEMBL24023335 0.74 PIK3CA (0.41) MAPK14IKBKBMAPK13PRKD3MAP4K4
SCHEMBL24023393 0.71 PIK3CA (0.48) PI4KB
SCHEMBL3085308 0.70 PIK3CD (0.52) SMN1; SMN2LMNAALDH1A1MEN1GAA
SCHEMBL24023338 0.69 XIAP (0.34) LMNAALDH1A1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353607-A1 PI3K INHIBITORS AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353607-A1 PI3K INHIBITORS AND USES THEREOF PIK3CA, AKT3, GSK3B CDC7 1753/4885DBF4 4835/4885MAPK14 396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback